These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34551598)

  • 1. Walking Impairment Questionnaire and Walking Tests are Reliable Indicators of Success of Treatment of Peripheral Artery Disease.
    Poredos P; Boc V; Zlajpah U; Mangaroska AS; Poredos P
    Angiology; 2022 Apr; 73(4):331-337. PubMed ID: 34551598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the walking impairment questionnaire as a measure of functional assessment.
    Poredos P; Zlajpah U; Poredos P; Mangaroska AS; Jezovnik MK
    Vasa; 2021 Jul; 50(4):286-293. PubMed ID: 33661020
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between calf muscle oxygen saturation with ambulatory function and quality of life in symptomatic patients with peripheral artery disease.
    Gardner AW; Montgomery PS; Wang M; Shen B
    J Vasc Surg; 2020 Aug; 72(2):632-642. PubMed ID: 32081480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of exercise ankle-brachial index, pain-free walking distance and maximum walking distance with the Peripheral Artery Questionnaire: Finding from the PORTRAIT PAD Registry.
    Hammad TA; Smolderen KG; Spertus JA; Jones PG; Shishehbor MH
    Vasc Med; 2019 Feb; 24(1):32-40. PubMed ID: 29992849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease.
    McDermott MM; Ferrucci L; Guralnik JM; Dyer AR; Liu K; Pearce WH; Clark E; Liao Y; Criqui MH
    Vasc Med; 2010 Aug; 15(4):251-7. PubMed ID: 20511294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance: 12 Month Results of a Controlled Randomised Multicentre Trial.
    Lindgren H; Qvarfordt P; Åkesson M; Bergman S; Gottsäter A;
    Eur J Vasc Endovasc Surg; 2017 May; 53(5):686-694. PubMed ID: 28372983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gujarati translation, validity and reliability of Walking Impairment Questionnaire in people with intermittent claudication due to peripheral artery disease.
    Naiyra D; Gohil MN; Shah H; Raval DM; Bearne LM
    J Vasc Nurs; 2024 Mar; 42(1):1-9. PubMed ID: 38555172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.
    Murphy TP; Reynolds MR; Cohen DJ; Regensteiner JG; Massaro JM; Cutlip DE; Mohler ER; Cerezo J; Oldenburg NC; Thum CC; Goldberg S; Hirsch AT
    J Vasc Interv Radiol; 2013 Oct; 24(10):1427-35; quiz 1436. PubMed ID: 23906799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese translation and validation of the Walking Impairment Questionnaire in patients with peripheral artery disease.
    Yan BP; Lau JY; Yu CM; Au K; Chan KW; Yu DS; Ma RC; Lam YY; Hiatt WR
    Vasc Med; 2011 Jun; 16(3):167-72. PubMed ID: 21636675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Lithuanian Version of the Walking Impairment Questionnaire in Patients with Peripheral Arterial Disease.
    Baltrūnas T; Medelis K; Melaikaitė A; Račytė A; Pikturnaitė G; Baltušnikas R; Laucevičienė I; Ručinskas K
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256407
    [No Abstract]   [Full Text] [Related]  

  • 11. A pilot exercise intervention to improve lower extremity functioning in peripheral arterial disease unaccompanied by intermittent claudication.
    McDermott MM; Tiukinhoy S; Greenland P; Liu K; Pearce WH; Guralnik JM; Unterreiner S; Gluckman TJ; Criqui MH; Ferrucci L
    J Cardiopulm Rehabil; 2004; 24(3):187-96. PubMed ID: 15235301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial.
    Poole J; Mavromatis K; Binongo JN; Khan A; Li Q; Khayata M; Rocco E; Topel M; Zhang X; Brown C; Corriere MA; Murrow J; Sher S; Clement S; Ashraf K; Rashed A; Kabbany T; Neuman R; Morris A; Ali A; Hayek S; Oshinski J; Yoon YS; Waller EK; Quyyumi AA
    JAMA; 2013 Dec; 310(24):2631-9. PubMed ID: 24247554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of walking distances estimated by the patient, on the corridor and on a treadmill, and the Walking Impairment Questionnaire in intermittent claudication.
    Frans FA; Zagers MB; Jens S; Bipat S; Reekers JA; Koelemay MJ
    J Vasc Surg; 2013 Mar; 57(3):720-727.e1. PubMed ID: 23313183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between meeting daily step count goals with ambulatory function and quality of life in patients with claudication.
    Gardner AW; Montgomery PS; Wang M; Shen B
    J Vasc Surg; 2021 Jun; 73(6):2105-2113. PubMed ID: 33253870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.
    Kurklinsky AK; Levy M
    Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the Walking Impairment Questionnaire a surrogate marker of 6-minute walking test performance in patients with peripheral artery disease with different degrees of claudication symptoms?
    Cunha PM; Kanegusuku H; Wolosker N; Correia MA; Cucato GG; Ritti-Dias RM
    J Cardiovasc Med (Hagerstown); 2023 Jun; 24(6):348-353. PubMed ID: 37115979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-based walking exercise for peripheral artery disease: An exploratory pilot study.
    Mays RJ; Hiatt WR; Casserly IP; Rogers RK; Main DS; Kohrt WM; Ho PM; Regensteiner JG
    Vasc Med; 2015 Aug; 20(4):339-47. PubMed ID: 25755148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication.
    Nicolaï SP; Kruidenier LM; Rouwet EV; Graffius K; Prins MH; Teijink JA
    J Vasc Surg; 2009 Jul; 50(1):89-94. PubMed ID: 19563956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease.
    Myers SA; Johanning JM; Stergiou N; Lynch TG; Longo GM; Pipinos II
    J Vasc Surg; 2008 Mar; 47(3):550-555. PubMed ID: 18207355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
    Regensteiner JG; Ware JE; McCarthy WJ; Zhang P; Forbes WP; Heckman J; Hiatt WR
    J Am Geriatr Soc; 2002 Dec; 50(12):1939-46. PubMed ID: 12473004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.